Cargando…
Let’s talk about mucormycosis emergency with COVID-19: Invest in future
Despite recent breakthroughs in the detection and treatment during the COVID-19 pandemic, mucormycosis is a serious infection with a high death rate. It is a filamentous fungal infection from the zygomycetes class of order mucorales. It is a fatal fungal infection with a 50% or higher overall fatali...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051722/ https://www.ncbi.nlm.nih.gov/pubmed/35495848 http://dx.doi.org/10.4103/jfmpc.jfmpc_1083_21 |
_version_ | 1784696624702816256 |
---|---|
author | Malik, Kamlesh Arora, Jyoti Yadav, Parvin K. Rohilla, Kusum K. |
author_facet | Malik, Kamlesh Arora, Jyoti Yadav, Parvin K. Rohilla, Kusum K. |
author_sort | Malik, Kamlesh |
collection | PubMed |
description | Despite recent breakthroughs in the detection and treatment during the COVID-19 pandemic, mucormycosis is a serious infection with a high death rate. It is a filamentous fungal infection from the zygomycetes class of order mucorales. It is a fatal fungal infection with a 50% or higher overall fatality rate. Mucormycosis is a fungal infection caused by mucor, which is a mold that can be found in soil, rotting fruits, and vegetables. It can primarily affect the brain, lungs, and sinuses. It is very much fatal in patients with diabetes or who are highly immunocompromised such as patients with cancer. In addition to more than 50% mortality rate, surgical intervention may require necrotic tissue removal, which leads to severely disfiguring surgery. |
format | Online Article Text |
id | pubmed-9051722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-90517222022-04-30 Let’s talk about mucormycosis emergency with COVID-19: Invest in future Malik, Kamlesh Arora, Jyoti Yadav, Parvin K. Rohilla, Kusum K. J Family Med Prim Care Commentary Despite recent breakthroughs in the detection and treatment during the COVID-19 pandemic, mucormycosis is a serious infection with a high death rate. It is a filamentous fungal infection from the zygomycetes class of order mucorales. It is a fatal fungal infection with a 50% or higher overall fatality rate. Mucormycosis is a fungal infection caused by mucor, which is a mold that can be found in soil, rotting fruits, and vegetables. It can primarily affect the brain, lungs, and sinuses. It is very much fatal in patients with diabetes or who are highly immunocompromised such as patients with cancer. In addition to more than 50% mortality rate, surgical intervention may require necrotic tissue removal, which leads to severely disfiguring surgery. Wolters Kluwer - Medknow 2022-03 2022-03-10 /pmc/articles/PMC9051722/ /pubmed/35495848 http://dx.doi.org/10.4103/jfmpc.jfmpc_1083_21 Text en Copyright: © 2022 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Commentary Malik, Kamlesh Arora, Jyoti Yadav, Parvin K. Rohilla, Kusum K. Let’s talk about mucormycosis emergency with COVID-19: Invest in future |
title | Let’s talk about mucormycosis emergency with COVID-19: Invest in future |
title_full | Let’s talk about mucormycosis emergency with COVID-19: Invest in future |
title_fullStr | Let’s talk about mucormycosis emergency with COVID-19: Invest in future |
title_full_unstemmed | Let’s talk about mucormycosis emergency with COVID-19: Invest in future |
title_short | Let’s talk about mucormycosis emergency with COVID-19: Invest in future |
title_sort | let’s talk about mucormycosis emergency with covid-19: invest in future |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051722/ https://www.ncbi.nlm.nih.gov/pubmed/35495848 http://dx.doi.org/10.4103/jfmpc.jfmpc_1083_21 |
work_keys_str_mv | AT malikkamlesh letstalkaboutmucormycosisemergencywithcovid19investinfuture AT arorajyoti letstalkaboutmucormycosisemergencywithcovid19investinfuture AT yadavparvink letstalkaboutmucormycosisemergencywithcovid19investinfuture AT rohillakusumk letstalkaboutmucormycosisemergencywithcovid19investinfuture |